Results 21 to 30 of about 84,994 (214)

Successful perioperative management of simultaneous transcatheter aortic valve implantation and hip fracture surgery: a case report [PDF]

, 2023
A 90-year-old woman with severe aortic stenosis experienced hospital readmission for chronic heart failure exacerbations many times and was admitted to our hospital for undergoing transcatheter aortic valve implantation.
Aoki, Yohei, Momohara, Hironori, Nonogaki, Mikio, Aoyama, Tadashi, Yamane, Kochi   +4 more
core   +1 more source

India’s first percutaneous tricuspid valve implantation: Valve-in-valve is a treatment option for bioprosthetic valve dysfunction

IHJ Cardiovascular Case Reports, 2017
Bioprosthetic valve dysfunction leading to haemodynamically significant consequences is well recognised. Traditional treatment of choice has been conventional re-do surgical valve replacement. However, over the last decade, percutaneous solutions such as
A.B. Gopalamurugan, R. Mohamed Abubacker, Prashant Vaijyanath   +2 more
doaj   +1 more source

Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. [PDF]

, 2012
BACKGROUND: Transcatheter aortic-valve replacement (TAVR) is the recommended therapy for patients with severe aortic stenosis who are not suitable candidates for surgery. The outcomes beyond 1 year in such patients are not known.
Makkar, Raj R, Dewey, Todd M, Pocock, Stuart, Brown, David L, Pichard, Augusto D, Bowers, Bruce, Siegel, Robert J, Smith, Craig R, Webb, John G, Tuzcu, Murat, Moses, Jeffrey W, Williams, Matthew R, Babaliaros, Vasilis C, Thourani, Vinod H, Kapadia, Samir, Svensson, Lars G, Jilaihawi, Hasan, Kodali, Susheel, Bavaria, Joseph E, MD, Fontana, Gregory P, Akin, Jodi J, Douglas, Pamela S, Bavaria, Joseph E, Herrmann, Howard C, Leon, Martin B, PARTNER Trial Investigators, Anderson, William N   +26 more
core   +1 more source

Transcatheter treatment for tricuspid valve disease. [PDF]

, 2021
Approximately 4% of subjects aged 75 years or more have clinically relevant tricuspid regurgitation (TR). Primary TR results from anatomical abnormality of the tricuspid valve apparatus and is observed in only 8-10% of the patients with tricuspid valve ...
Maisano, Francesco, Praz, F., Kreidel, F., Mangieri, A., Prendergast, B.D., Muraru, Denisa, Hahn, Rebecca T, Zamorano, Jose L, Mangieri, Antonio, Zamorano, J.L., von Bardeleben, Ralph Stephan, Hausleiter, Jörg, Maisano, F., Nickenig, G., Prendergast, Bernard D, Bardeleben, R.S. von, Senni, Michele, Nickenig, Georg, Delgado, V., Praz, Fabien, Lurz, P., Senni, M., Delgado, Victoria, Hausleiter, J., Lurz, Philipp, Hahn, R.T., Kreidel, Felix, Muraru, D.   +27 more
core   +2 more sources

India’s first successful ECMO assisted TAVI: A strategy for ‘high risk’ TAVI patients

IHJ Cardiovascular Case Reports, 2017
Transcatheter Aortic Valve Implantation (TAVI) is a well established treatment for patients with symptomatic aortic stenosis and who are high risk for conventional surgical aortic valve replacement.
A.B. Gopalamurugan, M.S. Meenakshi, R. Mohamed Abubacker   +2 more
doaj   +1 more source

Coronary revascularization after surgical aortic valve replacementCentral MessagePerspective

JTCVS Open, 2020
Objective: It remains unclear how often coronary revascularization is necessary after aortic valve interventions, either by surgical aortic valve replacement (SAVR) or transcatheter aortic valve replacement. However, these data are relevant for treatment
Mevlüt Çelik, BSc, Andras P. Durko, MD, Stuart J. Head, MD, PhD, Edris A.F. Mahtab, MD, PhD, Nicolas M. van Mieghem, MD, PhD, Paul A. Cummins, MSc, Arie P. Kappetein, MD, PhD, Ad.J.J.C. Bogers, MD, PhD   +7 more
doaj   +1 more source

Transcatheter Exclusion of a Large Pseudoaneurysm of a Systemic Right Ventricular Outflow Tract

JACC: Case Reports, 2021
We describe a rare patient with a large pseudoaneurysm of the right ventricular outflow tract that had developed after placement of a right ventricle–pulmonary artery conduit. A 7-mm Amplatzer Septal Occluder device was used to exclude the pseudoaneurysm,
James S. Krulisky, MD, Timothy Pettitt, MD, Ernest Siwik, MD, Kiran K. Mallula, MD   +3 more
doaj   +1 more source

Cost-utility of transcatheter aortic valve implantation for inoperable patients with severe aortic stenosis treated by medical management: a UK cost-utility analysis based on patient-level data from the ADVANCE study. [PDF]

, 2014
OBJECTIVE: To use patient-level data from the ADVANCE study to evaluate the cost-effectiveness of transcatheter aortic valve implantation (TAVI) compared to medical management (MM) in patients with severe aortic stenosis from the perspective of the UK ...
Busca, R, Axel Linke, Amie Padhiar, Peter Wenaweser, Neil Moat, Piazza, N, Stuart Mealing, Johan Bosmans, Mealing, S, Stephen Brecker, Mark Sculpher, Ulrich J Gerckens, Nicolo Piazza, Rachele Busca, Padhiar, A, Sabine Bleiziffer, Tamburino, C, Sculpher, M, Bosmans, J, Gerckens, UJ, Bleiziffer, S, Linke, A, James Eaton, Eaton, J, Wenaweser, P, Moat, N, Corrado Tamburino, Brecker, S, Brecker, Stephen, Mealing, Stuart, Padhiar, Arnie, et al., Bosmans, Johan   +32 more
core   +1 more source

Transcatheter Electrosurgery

Journal of the American College of Cardiology, 2020
Transcatheter electrosurgery refers to a family of procedures using radiofrequency energy to vaporize and traverse or lacerate tissue despite flowing blood. The authors review theory, simulations, and benchtop demonstrations of how guidewires, insulation, adjunctive catheters, and dielectric medium interact.
Jaffar M, Khan, Toby, Rogers, Adam B, Greenbaum, Vasilis C, Babaliaros, Dursun Korel, Yildirim, Christopher G, Bruce, Daniel A, Herzka, William H, Schenke, Kanishka, Ratnayaka, Robert J, Lederman   +9 more
openaire   +2 more sources

Multimodality Treatment with Conventional Transcatheter Arterial Chemoembolization and Radiofrequency Ablation for Unresectable Hepatocellular Carcinoma [PDF]

, 2011
Background/Aims: To evaluate the efficacy of multimodality treatment consisting of conventional transcatheter arterial chemoembolization (TACE) and radiofrequency ablation (RFA) in patients with non-resectable and non-ablatable hepatocellular carcinoma ...
Rentsch, M., P. Paprottka, F.T. Kolligs, M. Rentsch, Paprottka, P., T.F. Jakobs, Kolligs, F. T., Reiser, Maximilian F., Jakobs, T. F., Ashoori, N., F. Bamberg, Bamberg, F., Trumm, C., N. Ashoori, C. Trumm, M.F. Reiser   +15 more
core   +1 more source